Back to search

Abecarnil, a new beta-carboline, in the treatment of anxiety disorders

Data up to Jan 2025

Published1998
Citations29
References26

Total Citations Per Year

Abstract

References (26)

THE ASSESSMENT OF ANXIETY STATES BY RATING

1959 • 10,517 citations

REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

1969 • 384 citations

User's guide for the Structured clinical interview for DSM-III-R : SCID

1990 • 352 citations

Long-term Therapeutic Use of Benzodiazepines

1990 • 318 citations

The empirical basis of generalized anxiety disorder

1994 • 315 citations

The benzodiazepines: from molecular biology to clinical practice

1984 • 293 citations

Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment

1984 • 178 citations

The association between premenstrual dysphoric disorder and other mood disorders.

1997 • 155 citations

Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

1990 • 130 citations

ZK 91296, a partial agonist at benzodiazepine receptors

1984 • 107 citations

Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.

1990 • 84 citations

?-Carbolines can enhance or antagonize the effects of punishment in mice

1985 • 82 citations

Comparative Assessment of Efficacy and Withdrawal Symptoms After 6 and 12 Weeks' Treatment with Diazepam or Buspirone

1989 • 74 citations

Placebo response in generalized anxiety: its effect on the outcome of clinical trials.

1997 • 62 citations

Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

1995 • 59 citations

Benzodiazepines

1994 • 52 citations

The dependence potential of short half-life benzodiazepines: a meta-analysis.

1993 • 51 citations

PRIMARY DEPRESSION OR PRIMARY ANXIETY? A POSSIBLE PSYCHOMETRIC APPROACH TO A DIAGNOSTIC DILEMMA

1984 • 40 citations

A Double-Blind Evaluation of the Safety and Efficacy of Abecarnil, Alprazolam, and Placebo in Outpatients With Generalized Anxiety Disorder

1997 • 38 citations

Abecarnil is a Full Agonist at Some, and a Partial Agonist at Other Recombinant GABAA Receptor Subtypes

1993 • 35 citations

Human studies on abecarnil a new beta‐carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

1993 • 26 citations

Clinical perspectives of β-carbolines from first studies in humans

1987 • 25 citations

Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.

1997 • 22 citations

A Comparative Study of Suriclone, Lorazepam and Placebo in Anxiety Disorder

1989 • 22 citations

Abecarnil: A Novel Anxiolytic with Mixed Full Agonist/Partial Agonist Properties in Animal Models of Anxiety and Sedation

1993 • 19 citations

[Treatment of generalized anxiety: new pharmacologic approaches].

1995 • 6 citations

Cited By (0)

Loading...